Accurate assessment of cause of death (COD) is important for determin-ing cause-specific survival in cancer re-search. It is possible to reliably ascertain COD by meticulous review of inpatient and outpatient medical records with the use of predetermined clinical algorithms (1). Unfortunately, this method, al-though useful for small retrospective studies, is impractical for large datasets and national tumor registries that are commonly used for cancer research. When these large databases are used, COD is assigned with a standardized de-cision algorithm that uses International Classification of Diseases, ninth revi-sion (2), codes to assign both immediate and underlying COD (3). However, this methodology is unreliable (4,5), particu-larly wh...
OBJECTIVE: The purpose of this study was to examine the proportion of men who died from prostate can...
Abstract Background Registration and coding of cause of death is prone to error since determining th...
Background:The European Randomised Study of Prostate Cancer Screening has shown a 21% relative reduc...
Accurate cause of death assignment is crucial for prostate cancer epidemiology and trials reporting ...
Background: Accurate cause of death assignment is crucial for prostate cancer epidemiology and trial...
BACKGROUND: Accurate cause of death assignment is crucial for prostate cancer epidemiology and trial...
BackgroundThe National Death Index (NDI) is a centralized database containing information from death...
OBJECTIVE: To investigate causes of death in a UK cohort of patients with prostate cancer. PATIENTS ...
Background: To assess the agreement between the causes of death assigned by a blinded and uniform re...
Background. A recent rise in the incidence of prostate cancer and a more favorable outcome have incr...
Death certificates are used to classify cause of death for studies of cancer survival and mortality....
Background: Prostate cancer tends to affect older men and to progress relatively slowly. Since the p...
Introduction: Coded cause of death data from death certificates is important for estimating mortalit...
Background: Cause of death (COD) information taken from death certificates is often inaccurate and i...
autopsied population with specific attention to malignant neoplasms and vas-cular diseases. Am J Epi...
OBJECTIVE: The purpose of this study was to examine the proportion of men who died from prostate can...
Abstract Background Registration and coding of cause of death is prone to error since determining th...
Background:The European Randomised Study of Prostate Cancer Screening has shown a 21% relative reduc...
Accurate cause of death assignment is crucial for prostate cancer epidemiology and trials reporting ...
Background: Accurate cause of death assignment is crucial for prostate cancer epidemiology and trial...
BACKGROUND: Accurate cause of death assignment is crucial for prostate cancer epidemiology and trial...
BackgroundThe National Death Index (NDI) is a centralized database containing information from death...
OBJECTIVE: To investigate causes of death in a UK cohort of patients with prostate cancer. PATIENTS ...
Background: To assess the agreement between the causes of death assigned by a blinded and uniform re...
Background. A recent rise in the incidence of prostate cancer and a more favorable outcome have incr...
Death certificates are used to classify cause of death for studies of cancer survival and mortality....
Background: Prostate cancer tends to affect older men and to progress relatively slowly. Since the p...
Introduction: Coded cause of death data from death certificates is important for estimating mortalit...
Background: Cause of death (COD) information taken from death certificates is often inaccurate and i...
autopsied population with specific attention to malignant neoplasms and vas-cular diseases. Am J Epi...
OBJECTIVE: The purpose of this study was to examine the proportion of men who died from prostate can...
Abstract Background Registration and coding of cause of death is prone to error since determining th...
Background:The European Randomised Study of Prostate Cancer Screening has shown a 21% relative reduc...